Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment

References

• Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999). Antipsychotic-induced weight gain: a comprehensive research synthesis. The American Journal of Psychiatry, 156, 1686–1696.
   PubMed Web of Science ®Google Scholar
• Almandil, N. B., Liu, Y., Murray, M. L., Besag, F. M. C., Aitchison, K. J., & Wong, I. C. K. (2013). Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Pediatric Drugs, 15, 139–150. doi:10.1007/s40272-013-0016-6
   PubMed Web of Science ®Google Scholar
• Alves, D., Costa, A. F., & Custódio, D. (2011). Housing and employment situation, body mass index and dietary habits of heroin addicts in methadone maintenance treatment. Heroin Addiction and Related Clinical Problems, 13, 11–14
   Web of Science ®Google Scholar
• Arterburn, D., Wood, G. C., Theis, M. K., Westbrook, E. O., Anau, J., Rukstalis, M., … Gerhard, G. S. (2016). Antipsychotic medications and extreme weight gain in two health systems. Obesity Research & Clinical Practice, 10, 408–423. doi:10.1016/j.orcp.2015.08.012
   PubMed Web of Science ®Google Scholar
• Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014). Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One, 9, e94112 doi:10.1371/journal.pone.0094112
   PubMed Web of Science ®Google Scholar
• Biedermann, F., Fleischhacker, W. W., Kemmler, G., Ebenbichler, C. F., Lechleitner, M., & Hofer, A. (2014). Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophrenia. International Clinical Psychopharmacology, 29, 181–184. doi:10.1097/YIC.0000000000000022
   PubMed Web of Science ®Google Scholar
• Blumenthal, S. R., Castro, V. M., Clements, C. C., Rosenfield, H. R., Murphy, S. N., Fava, M., … Perlis, R. H. (2014). An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry, 71, 889–896. doi:10.1001/jamapsychiatry.2014.414
   PubMed Web of Science ®Google Scholar
• Brady, K. T., McCauley, J. L., & Back, S. E. (2016). Prescription opioid misuse, abuse, and treatment in the United States: An update. American Journal of Psychiatry, 173, 18–26. doi:10.1176/appi.ajp.2015.15020262
   PubMed Web of Science ®Google Scholar
• Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Department of Heath & Human Services.
   Google Scholar
• Connery, H. S. (2015). Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions. Harvard Review of Psychiatry, 23, 63. doi:10.1097/HRP.0000000000000075
   PubMed Web of Science ®Google Scholar
• Cortés, B., Bécker, J., Mories Álvarez, M. T., Marcos, A. I. S., & Molina, V. (2014). Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia. Psychiatry and Clinical Neurosciences, 68, 127–132. doi:10.1111/pcn.12110
   PubMed Web of Science ®Google Scholar
• Curtis, J., Watkins, A., Rosenbaum, S., Teasdale, S., Kalucy, M., Samaras, K., & Ward, P. B. (2016). Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis. Early Intervention in Psychiatry, 10, 267–276. doi:10.1111/eip.12230
   PubMed Web of Science ®Google Scholar
• de Silva, V. A., Dayabandara, M., Wijesundara, H., Henegama, T., Gunewardena, H., Suraweera, C., & Hanwella, R. (2015). Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study. Journal of Psychopharmacology (Oxford), 29, 1255–1261. doi:10.1177/0269881115613519
   PubMed Web of Science ®Google Scholar
• Fenn, J. M., Laurent, J. S., & Sigmon, S. C. (2015). Increases in body mass index following initiation of methadone treatment. Journal of Substance Abuse Treatment, 51, 59–63. doi:10.1016/j.jsat.2014.10.007
   PubMed Web of Science ®Google Scholar
• GBD 2015 Obesity Collaborators. (2017). Health effects of overweight and obesity in 195 countries over 25 years. The New England Journal of Medicine, 377, 13–27. doi:10.1056/NEJMoa1614362
   PubMed Web of Science ®Google Scholar
• Ghanizadeh, A., Nikseresht, M. S., & Sahraian, A. (2013). The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial. Schizophrenia Research, 147, 110–115. doi:10.1016/j.schres.2013.03.021
   PubMed Web of Science ®Google Scholar
• Goldberg, J. F., & Ernst, C. L. (2012). Managing the side effects of psychotropic medications. Arlington, VA: American Psychiatric Association Publishing.
   Google Scholar
• Harris, C. M., Cheskin, L. J., Khaliq, W., Antoine, D., Landis, R., Steinberg, E. M., & Wright, S. (2016). Hospitalists’ utilization of weight loss resources with discharge texts and primary care contact: a feasibility study. Hospital Practice, 44, 98–102. doi:10.1080/21548331.2016.1155396
   PubMedGoogle Scholar
• Himmerich, H., Minkwitz, J., & Kirkby, K. C. (2015). Weight gain and metabolic changes during treatment with antipsychotics and antidepressants. Endocrine, Metabolic & Immune Disorders Drug Targets, 15, 252–260. doi:10.2174/1871530315666150623092031
   PubMed Web of Science ®Google Scholar
• Jarskog, L. F., Hamer, R. M., Catellier, D. J., Stewart, D. D., LaVange, L., Ray, N. … (2013). Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. The American Journal of Psychiatry, 170, 1032–1040. doi:10.1176/appi.ajp.2013.12010127
   PubMed Web of Science ®Google Scholar
• Jeynes, K. D., & Gibson, E. L. (2017). The importance of nutrition in aiding recovery from substance use disorders: a review. Drug and Alcohol Dependence, 179, 229–239. doi:10.1016/j.drugalcdep.2017.07.006
   PubMed Web of Science ®Google Scholar
• Kelley, A. E., & Berridge, K. C. (2002). The neuroscience of natural rewards: relevance to addictive drugs. Journal of Neuroscience, 22, 3306–3311. doi:10.1523/JNEUROSCI.22-09-03306.2002
   PubMed Web of Science ®Google Scholar
• Kloiber, S., Domschke, K., Ising, M., Arolt, V., Baune, B. T., Holsboer, F., & Lucae, S. (2015). Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. The Journal of Clinical Psychiatry, 76, e802–e808. doi:10.4088/JCP.14m09212
   PubMed Web of Science ®Google Scholar
• Liu, Y.-T., Chau, Y.-L., Hsu, S.-C., Chu, C.-L., & Chen, C.-Y. (2014). Factors influencing weight gain in an Asian population of psychiatric inpatients: a retrospective study in Taiwan. Asia-Pacific Psychiatry: Official Journal of the Pacific Rim College of Psychiatrists, 6, 226–234. doi:10.1111/j.1758-5872.2012.00223.x
   PubMed Web of Science ®Google Scholar
• Lovell, K., Wearden, A., Bradshaw, T., Tomenson, B., Pedley, R., Davies, L. M., … Marshall, M. (2014). An exploratory randomized controlled study of a healthy living intervention in early intervention services for psychosis: the INTERvention to encourage ACTivity, improve diet, and reduce weight gain (INTERACT) study. The Journal of Clinical Psychiatry, 75, 498–505. doi:10.4088/JCP.13m08503
   PubMed Web of Science ®Google Scholar
• Manu, P., Dima, L., Shulman, M., Vancampfort, D., De Hert, M., & Correll, C. U. (2015). Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatrica Scandinavica, 132, 97–108. doi:10.1111/acps.12445
   PubMed Web of Science ®Google Scholar
• Martínez-Ortega, J. M., Funes-Godoy, S., Díaz-Atienza, F., Gutiérrez-Rojas, L., Pérez-Costillas, L., & Gurpegui, M. (2013). Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review. European Child & Adolescent Psychiatry, 22, 457–479. doi:10.1007/s00787-013-0399-5
   PubMed Web of Science ®Google Scholar
• Maxmen, J. S., Kennedy, S. H., & McIntyre, R. S. (2008). Psychotropic drugs: Fast facts. New York, NY: W. W. Norton & Company.
   Google Scholar
• Mehta, V. S., & Ram, D. (2016). Efficacy of ranitidine in olanzapine-induced weight gain: a dose-response study. Early Intervention in Psychiatry, 10, 522–527. doi:10.1111/eip.12205
   PubMed Web of Science ®Google Scholar
• Merz, F. (2018). United Nations office on drugs and crime: World drug report 2017. SIRIUS - Zeitschrift Für Strategische Analysen, 2, 85–86. doi:10.1515/sirius-2018-0016
   Google Scholar
• Musil, R., Obermeier, M., Russ, P., & Hamerle, M. (2015). Weight gain and antipsychotics: a drug safety review. Expert Opinion on Drug Safety, 14, 73–96. doi:10.1517/14740338.2015.974549
   PubMed Web of Science ®Google Scholar
• Mysels, D. J., Vosburg, S. K., Benga, I., Levin, F. R., & Sullivan, M. A. (2011). Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients. Journal of Opioid Management, 7, 47–53. doi:10.5055/jom.2011.0048
   PubMedGoogle Scholar
• Nolan, L. J., & Scagnelli, L. M. (2007). Preference for sweet foods and higher body mass index in patients being treated in long-term methadone maintenance. Subst Use Misuse, 42, 1555–1566. doi:10.1080/10826080701517727
   PubMed Web of Science ®Google Scholar
• Okruhlica, L., & Slezakova, S. (2008). Weight gain among the patients in methadone maintenance program as come-back to population norm. Cas Lek Cesk, 147, 426–430.
   Google Scholar
• Peles, E., Schreiber, S., Hetzroni, T., Adelson, M., & Defrin, R. (2011). The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. The Journal of Pain, 12, 41–50. doi:10.1016/j.jpain.2010.04.009
   PubMed Web of Science ®Google Scholar
• Peles, E., Schreiber, S., Sason, A., & Adelson, M. (2016). Risk factors for weight gain during methadone maintenance treatment. Substance Abuse, 37, 613–618. doi:10.1080/08897077.2016.1179705
   PubMed Web of Science ®Google Scholar
• Pérez-Iglesias, R., Martínez-García, O., Pardo-Garcia, G., Amado, J. A., Garcia-Unzueta, M. T., Tabares-Seisdedos, R., & Crespo-Facorro, B. (2014). Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors. The International Journal of Neuropsychopharmacology, 17, 41–51. doi:10.1017/S1461145713001053
   PubMed Web of Science ®Google Scholar
• Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., & Zito, J. M. (1998). Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialties. JAMA: The Journal of the American Medical Association, 279, 526–531. doi:10.1001/jama.279.7.526
   PubMed Web of Science ®Google Scholar
• Ponizovsky, A. M., Rosca, P., Haklai, Z., & Goldberger, N. (2015). Trends in dual diagnosis of severe mental illness and substance use disorders, 1996-2010, Israel. Drug Alcohol Depend, 148, 203–208. doi:10.1016/j.drugalcdep.2015.01.009
   PubMed Web of Science ®Google Scholar
• Richardson, R. A., & Wiest, K. (2015). A preliminary study examining nutritional risk factors, body mass index, and treatment retention in opioid-dependent patients. The Journal of Behavioral Health Services & Research, 42, 401–408. doi:10.1007/s11414-013-9371-x
   PubMed Web of Science ®Google Scholar
• Sason, A., Adelson, M., Herzman-Harari, S., & Peles, E. (2018). Knowledge about nutrition, eating habits and weight reduction intervention among methadone maintenance treatment patients. Journal of Substance Abuse Treatment, 86, 52–59. doi:10.1016/j.jsat.2017.12.008
   PubMed Web of Science ®Google Scholar
• Schuckit, M. A. (2016). Treatment of opioid-use disorders. The New England Journal of Medicine, 375, 357–368. doi:10.1056/NEJMra1604339
   PubMed Web of Science ®Google Scholar
• Subramaniam, M., Lam, M., Guo, M. E., He, V. Y. F., Lee, J., Verma, S., & Chong, S. A. (2014). Body mass index, obesity, and psychopathology in patients with schizophrenia. Journal of Clinical Psychopharmacology, 34, 40–46. doi:10.1097/JCP.0000000000000058
   PubMed Web of Science ®Google Scholar
• Uguz, F., Sahingoz, M., Gungor, B., Aksoy, F., & Askin, R. (2015). Weight gain and associated factors in patients using newer antidepressant drugs. General Hospital Psychiatry, 37, 46–48. doi:10.1016/j.genhosppsych.2014.10.011
   PubMed Web of Science ®Google Scholar
• United Nations Publications. (2017). World Drug Report 2017. UN, Vienna, Austria.
   Google Scholar
• US Burden of Disease Collaborators, Mokdad, A. H., Ballestros, K., Echko, M., Glenn, S., Olsen, H. E., … Murray, C. J. L. (2018). The state of US Health, 1990-2016: Burden of diseases, injuries, and risk factors among US states. JAMA: The Journal of the American Medical Association, 319, 1444–1472.
   PubMed Web of Science ®Google Scholar
• Webster, L. R. (2013). Methadone side effects: Constipation, respiratory depression, sedation, sleep-disordered breathing, and the endocrine system. In R. A. Cruciani & H. Knotkova (Eds.), Handbook of Methadone Prescribing and Buprenorphine Therapy (pp. 39–49). New York, NY: Springer New York.
   Google Scholar
• Wiss, D. A., Schellenberger, M., & Prelip, M. L. (2017). Registered dietitian nutritionists in substance use disorder treatment centers. Journal of the Academy of Nutrition and Dietetics, 509–532, doi:10.1016/j.jand.2017.08.113
   PubMedGoogle Scholar
• Wiss, D. A., & Waterhous, T. S. (2014). Nutrition therapy for eating disorders, substance use disorders, and addictions. In T. D. Brewerton & A. Baker Dennis (Eds.), Eating disorders, addictions and substance use disorders: Research, clinical and treatment perspectives (pp. 509–532). Berlin, Heidelberg: Springer Berlin Heidelberg.
   Google Scholar
• Zador, D., Lyons Wall, P. M., & Webster, I. (1996). High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia. Addiction, 91, 1053–1061. doi:10.1111/j.1360-0443.1996.tb03601.x
   PubMed Web of Science ®Google Scholar